-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, FoT6K98ggn/jJx1QrChs8JFYhb79/BX9MZAKmnYBiVyitPvDSVKy6v+dc0Z9zksY k1LLybjAWq2JMtfGlwcYzg== 0000930413-10-004883.txt : 20100924 0000930413-10-004883.hdr.sgml : 20100924 20100924205456 ACCESSION NUMBER: 0000930413-10-004883 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20100922 FILED AS OF DATE: 20100924 DATE AS OF CHANGE: 20100924 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Davit Paul Stephen CENTRAL INDEX KEY: 0001323791 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-12957 FILM NUMBER: 101089700 MAIL ADDRESS: STREET 1: DORSEY & WHITNEY LLP 250 PARK AVENUE CITY: NEW YORK STATE: NY ZIP: 10177 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ENZON PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000727510 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 222372868 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 685 ROUTE 202/206 CITY: BRIDGEWATER STATE: NJ ZIP: 08807 BUSINESS PHONE: 908 541 8671 MAIL ADDRESS: STREET 1: 685 ROUTE 202/206 STREET 2: ATT: GENERAL COUNSEL CITY: BRIDGEWATER STATE: NJ ZIP: 08807 FORMER COMPANY: FORMER CONFORMED NAME: ENZON PHARMACEUTICALS INC DATE OF NAME CHANGE: 20021211 FORMER COMPANY: FORMER CONFORMED NAME: ENZON PHARMACEUTICAL INC DATE OF NAME CHANGE: 20021210 FORMER COMPANY: FORMER CONFORMED NAME: ENZON INC DATE OF NAME CHANGE: 19920703 4 1 c62849_ex.xml X0303 4 2010-09-22 0 0000727510 ENZON PHARMACEUTICALS INC ENZN 0001323791 Davit Paul Stephen C/O ENZON PHARMACEUTICALS, INC. 685 ROUTE 202/206 BRIDGEWATER NJ 08807 0 1 0 0 Exec. Vice Pres. HR Common Stock 2010-09-22 4 A 0 8000 0 A 102737.1651 D Restricted Stock Units granted by the Issuer pursuant to its 2001 Incentive Stock Plan and qualified under Rule 16b-3(d). Each unit represents a contingent right to receive one share of the Issuer's Common Stock. The Restricted Stock Units shall vest in full on September 22, 2013 and do not have an expiration date; provided, however, that the vesting of 50% of the Restricted Stock Units shall be accelerated upon the Reporting Person's achievement of certain performance milestones determined by the Board of Directors of the Issuer. Exhibit List: Exhibit 24.1 Power of Attorney /s/ Andrew Rackear, Attorney-In-Fact 2010-09-24 EX-24.1 2 c62849_ex24-1.htm

POWER OF ATTORNEY

Know all by these presents, that the undersigned hereby constitutes and appoints Andrew Rackear the undersigned’s true and lawful attorney-in-fact to:

(1)

execute for and on behalf of the undersigned, in the undersigned’s capacity as an officer and/or director of Enzon Pharmaceuticals, Inc. (the “Company”), Forms 3, 4 and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder;

(2)

do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4 or 5 and timely file such form with the United States Securities and Exchange Commission and any stock exchange or similar authority; and

(3)

take any other action of any type whatsoever in connection with the foregoing which, in the opinion of the attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by the attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as the attorney-in-fact may approve in the attorney-in-fact’s discretion.

The undersigned hereby grants to the attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that the attorney-in-fact, or the attorney-in-fact’s substitute or substitutes, shall lawfully do or cause to be done by virtue of this Power of Attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorney-in-fact, in serving in such capacity at the request of the undersigned, is not assuming, nor is the Company assuming, any of the undersigned’s responsibilities to comply with Section 16 of the Securities Exchange Act of 1934.

This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4 and 5 with respect to the undersigned’s holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the attorney-in-fact.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of August 25, 2010.

/s/ Paul S. Davit
——————————————
Signature

Paul S. Davit
——————————————
Print Name

-----END PRIVACY-ENHANCED MESSAGE-----